Spaulding Clinical is a Phase 1 clinical trial facility with state-of-the-art services utilizing the most advanced technologies available to monitor, record, analyze and report trial data. With our unique specialization in cardiac safety testing for new drugs in development, Spaulding Clinical provides the highest quality clinical trial conduct—using the most efficient processes in the industry—resulting in the most accurate data possible.
“We are very excited to add MMS Holding’s Inc. capabilities to our comprehensive list of Phase 1 services,” noted Daniel Selness, Vice President of Operations, Spaulding Clinical. “As a robust clinical service provider, MMS Holdings Inc. is built on a strong foundation of science and quality and has a proven track record of delivering strong results for their clients. They are uniquely positioned to support Sponsors in data analyses, medical writing and overall development. Their expertise in regulatory requirements and submissions creates a high value to this partnership, keeping in mind the end-goal of a successful regulatory submission for our clients.”
“This partnership represents a significant milestone for us,” said Uma Sharma, Chief Scientific Officer for MMS Holdings Inc. “Spaulding Clinical shares our commitment to scientific excellence and innovative solutions. Well-planned and well-conducted phase 1 trials, especially in the area of cardiac safety, are of great importance to our clients and to regulators, and Spaulding Clinical provides the necessary scientific, operational and technological expertise in this area. We are very impressed with the Spaulding team and our combined strengths will bring increased value and high quality results to our clients; who in turn can deliver promising medications to patients who need them.”
About Spaulding Clinical
Spaulding Clinical is Phase 1 Clinical Research Unit and Cardiac Core Lab located in West Bend Wisconsin. Spaulding Clinical offers a range of services including definitive QTc (TQT) studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, food effect, PK/PD characterization and data collection and management. Spaulding Clinical also offers a full suite of Cardiac Core Lab and Over-reading services with state-of-the art technology and cardiac expertise.
About MMS Holdings Inc.
MMS Holdings Inc. is based in Canton, MI and is a highly experienced pharmaceutical service organization that is focused on quality deliverables in the areas of Clinical Programming, Biostatistics, Medical /Regulatory Writing and Comprehensive Pharmacovigilance. Commitment to Quality deliverables with robust submission experience sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO-9001 certified for all services and maintains detailed quality metrics for every project.
